tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AU:TYP Stock Latest News

Tryptamine Therapeutics Releases Options from Escrow to Boost Clinical Developments
Company AnnouncementsTryptamine Therapeutics Releases Options from Escrow to Boost Clinical Developments
7d ago
Tryptamine Therapeutics Appoints New Chairman to Strengthen Strategic Direction
PremiumCompany Announcements
Tryptamine Therapeutics Appoints New Chairman to Strengthen Strategic Direction
7d ago
Tryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder
PremiumCompany Announcements
Tryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder
7d ago
Tryptamine Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Tryptamine Therapeutics Announces Cessation of Securities
21d ago
TYP
Tryptamine Therapeutics Releases Options from Escrow and Advances Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Releases Options from Escrow and Advances Clinical Trials
24d ago
TYP
Tryptamine Therapeutics Announces Director Resignation
PremiumCompany AnnouncementsTryptamine Therapeutics Announces Director Resignation
26d ago
TYP
Tryptamine Therapeutics Strengthens Leadership with New Chairman Appointment
Premium
Company Announcements
Tryptamine Therapeutics Strengthens Leadership with New Chairman Appointment
28d ago
TYP
Tryptamine Therapeutics to Launch Pioneering Clinical Trial for Binge Eating Disorder
Premium
Company Announcements
Tryptamine Therapeutics to Launch Pioneering Clinical Trial for Binge Eating Disorder
1M ago
TYP
Tryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder Treatment
PremiumCompany Announcements
Tryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder Treatment
2M ago
TYP
Tryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
2M ago
Tryptamine Therapeutics Announces New Company Secretary Amid Ongoing Clinical Developments
PremiumCompany Announcements
Tryptamine Therapeutics Announces New Company Secretary Amid Ongoing Clinical Developments
2M ago
Tryptamine Therapeutics Announces Change in Substantial Shareholding
PremiumCompany Announcements
Tryptamine Therapeutics Announces Change in Substantial Shareholding
2M ago
TYP
Tryptamine Therapeutics Appoints New Company Secretary Amid Strategic Advancements
PremiumCompany AnnouncementsTryptamine Therapeutics Appoints New Company Secretary Amid Strategic Advancements
2M ago
TYP
Tryptamine Therapeutics Enhances Director’s Stake Amid Strategic Growth
Premium
Company Announcements
Tryptamine Therapeutics Enhances Director’s Stake Amid Strategic Growth
2M ago
TYP
Tryptamine Therapeutics Announces Director’s Interest Changes
Premium
Company Announcements
Tryptamine Therapeutics Announces Director’s Interest Changes
2M ago
TYP
Tryptamine Therapeutics Updates Director’s Securities Holdings
PremiumCompany Announcements
Tryptamine Therapeutics Updates Director’s Securities Holdings
2M ago
TYP
Tryptamine Therapeutics Issues New Equity Securities
PremiumCompany Announcements
Tryptamine Therapeutics Issues New Equity Securities
2M ago
TYP
Tryptamine Therapeutics Issues 162 Million Unquoted Equity Securities
PremiumCompany Announcements
Tryptamine Therapeutics Issues 162 Million Unquoted Equity Securities
2M ago
TYP
Tryptamine Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Tryptamine Therapeutics Lists New Securities on ASX
2M ago
TYP
Tryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
PremiumCompany AnnouncementsTryptamine Therapeutics Gains Shareholder Support and Advances Clinical Trials
3M ago
TYP
Tryptamine Therapeutics Reports Increased Losses Amid Revenue Decline
Premium
Company Announcements
Tryptamine Therapeutics Reports Increased Losses Amid Revenue Decline
3M ago
TYP
Tryptamine Therapeutics Updates Security Issuance Proposal
Premium
Company Announcements
Tryptamine Therapeutics Updates Security Issuance Proposal
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >